These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25467845)

  • 1. Dysfunctional high-density lipoproteins in children with chronic kidney disease.
    Kaseda R; Jabs K; Hunley TE; Jones D; Bian A; Allen RM; Vickers KC; Yancey PG; Linton MF; Fazio S; Kon V
    Metabolism; 2015 Feb; 64(2):263-73. PubMed ID: 25467845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
    Kaseda R; Tsuchida Y; Yang HC; Yancey PG; Zhong J; Tao H; Bian A; Fogo AB; Linton MRF; Fazio S; Ikizler TA; Kon V
    BMC Nephrol; 2018 Jan; 19(1):17. PubMed ID: 29374468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patients.
    Maeba R; Kojima KI; Nagura M; Komori A; Nishimukai M; Okazaki T; Uchida S
    Atherosclerosis; 2018 Mar; 270():102-109. PubMed ID: 29407877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.
    Kon V; Yang H; Fazio S
    Arch Med Res; 2015 Jul; 46(5):379-91. PubMed ID: 26009251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.
    Rastogi A
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.
    Shroff R; Speer T; Colin S; Charakida M; Zewinger S; Staels B; Chinetti-Gbaguidi G; Hettrich I; Rohrer L; O'Neill F; McLoughlin E; Long D; Shanahan CM; Landmesser U; Fliser D; Deanfield JE
    J Am Soc Nephrol; 2014 Nov; 25(11):2658-68. PubMed ID: 24854267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.
    Mao JY; Sun JT; Yang K; Shen WF; Lu L; Zhang RY; Tong X; Liu Y
    J Diabetes Complications; 2017 Oct; 31(10):1538-1543. PubMed ID: 28760652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
    Yamamoto S; Yancey PG; Ikizler TA; Jerome WG; Kaseda R; Cox B; Bian A; Shintani A; Fogo AB; Linton MF; Fazio S; Kon V
    J Am Coll Cardiol; 2012 Dec; 60(23):2372-9. PubMed ID: 23141484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells.
    Stannard AK; Khan S; Graham A; Owen JS; Allen SP
    Atherosclerosis; 2001 Jan; 154(1):31-8. PubMed ID: 11137080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.
    Cockerill GW; Rye KA; Gamble JR; Vadas MA; Barter PJ
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1987-94. PubMed ID: 7583580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.
    Rysz J; Gluba-Brzózka A; Rysz-Górzyńska M; Franczyk B
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
    Ganda A; Yvan-Charvet L; Zhang Y; Lai EJ; Regunathan-Shenk R; Hussain FN; Avasare R; Chakraborty B; Febus AJ; Vernocchi L; Lantigua R; Wang Y; Shi X; Hsieh J; Murphy AJ; Wang N; Bijl N; Gordon KM; de Miguel MH; Singer JR; Hogan J; Cremers S; Magnusson M; Melander O; Gerszten RE; Tall AR
    J Mol Cell Cardiol; 2017 Nov; 112():114-122. PubMed ID: 28478047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
    Marsche G; Heine GH; Stadler JT; Holzer M
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD.
    Hung AM; Tsuchida Y; Nowak KL; Sarkar S; Chonchol M; Whitfield V; Salas N; Dikalova A; Yancey PG; Huang J; Linton MF; Ikizler TA; Kon V
    Clin J Am Soc Nephrol; 2019 May; 14(5):702-711. PubMed ID: 31015261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.
    Cockerill GW; Huehns TY; Weerasinghe A; Stocker C; Lerch PG; Miller NE; Haskard DO
    Circulation; 2001 Jan; 103(1):108-12. PubMed ID: 11136694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
    Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
    Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic kidney disease on macrophage cholesterol efflux.
    Meier SM; Wultsch A; Hollaus M; Ammann M; Pemberger E; Liebscher F; Lambers B; Fruhwürth S; Stojakovic T; Scharnagl H; Schmidt A; Springer A; Becker J; Aufricht C; Handisurya A; Kapeller S; Röhrl C; Stangl H; Strobl W
    Life Sci; 2015 Sep; 136():1-6. PubMed ID: 26135622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport.
    Anderson JL; Gautier T; Nijstad N; Tölle M; Schuchardt M; van der Giet M; Tietge UJ
    Sci Rep; 2017 Feb; 7():41481. PubMed ID: 28148911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality.
    Muñoz-Vega M; Massó F; Páez A; Carreón-Torres E; Cabrera-Fuentes HA; Fragoso JM; Pérez-Hernández N; Martinez LO; Najib S; Vargas-Alarcón G; Pérez-Méndez Ó
    Lipids Health Dis; 2018 Mar; 17(1):44. PubMed ID: 29523150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.